New White Paper Analyzes Launches Since the Start of the COVID Pandemic to Profile Key Strategies that Improve Commercialization Success

Waltham, MA, October 2, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of Trinity Launch Accelerator 2.0 to provide smart, efficient launch planning with customized, tech-enabled support. Built and powered by Trinity’s Launch Center of Excellence (COE), Launch Accelerator 2.0 is an easy-to-use cloud-based project management tool that leverages recent “real world” launches to guide cross-functional Global Launch and Project Management Office (PMO) teams.

Trinity’s proprietary Launch Accelerator technology supports the unique needs of launching biopharma products globally with a modernized approach to launch planning, execution and tracking. The tool aids launch teams in creating customized roadmaps and detailed launch plans, conducting gaps/risks assessments and enabling streamlined cross-functional project management with a flexible, dynamic launch interface. Designed to accelerate transparency and alignment, Launch Accelerator 2.0 facilitates the launch process so that client teams can focus on effective and efficient execution. Collaboration and communications are streamlined with Gantt charts, dashboards and reports generated from the Launch Accelerator, all of which can be customized and configured by Trinity’s Launch Excellence COE.

Launch strategy, plan development and execution management vary greatly across—and even within—life sciences companies. The key to every successful launch is a deep understanding of the strategic vision and development of the priorities, people, processes and tools to enable the execution of that vision. Trinity’s Launch Excellence COE answers core questions that help clients prepare for commercialization through a portfolio of offerings, including strategic advisory with a unique “outside-in” perspective, proprietary benchmarks, tools and frameworks:

  • How do we effectively operationalize our launch strategy?
  • How do we know we are not missing anything, we have identified the risks, and we are leveraging benchmarks and best practices relevant for this launch?
  • How can we achieve cross-functional alignment—and accountability—on priorities?
  • Where are the cross-functional interdependencies? How can they be tracked and managed in a changing environment?
  • What does good launch excellence mean and how do we achieve it?

“No two launches in life sciences are the same—each asset is different, from the number of indications and markets to modality, site of care and countries in scope,” explained Herman Sanchez, Chief Business Officer at Trinity Life Sciences. “But even with this unique complexity, the combination of benchmark data and expert thought partnership can bring confidence in the path to successful commercialization.”

“It’s not just what you have to accomplish to prepare for commercialization, it’s the how,” added Krista Perry, Partner & Head of Launch Excellence at Trinity Life Sciences. “Trinity’s Launch Excellence team facilitates the process of execution in addition to crafting the plan—we help our clients cut through the noise to identify the right priorities, avoid the pitfalls and keep their teams focused. We built Launch Accelerator 2.0 to support cross-functional communication and engagement.”

Trinity Launch Accelerator 2.0
Trinity’s Launch Accelerator 2.0 offers customized, tech-enabled support for each client’s launch by leveraging recent “real world” launches to guide cross-functional global launch and PMO teams. It is part of TrinityEDGE, Trinity’s data and analytics platform. Launch Accelerator 2.0:

  • Enables workflow automation, customizable visualizations and streamlined cross-functional project management with a flexible, dynamic and user-friendly launch interface in the cloud
  • Offers flexibility and tailoring for each client’s situation and evolving needs
  • Allows for shorter project times, increased quality and accuracy in plan development and easy progress visibility at the leadership level
  • And much more…

New Launch White Paper Now Available
Fifty-eight percent of launches in life sciences have underperformed since the start of the COVID pandemic (late 2019 through 2022). Trinity discusses the strategies the industry needs to be thinking about to improve commercialization success in the new white paper What Lies Ahead for New Product Launches?

Life sciences executives are welcome to download the white paper here.

About TrinityEDGE™
TrinityEDGE is a data and analytics platform that accelerates action by reshaping information into insights. Life sciences companies derive actionable insights from TrinityEDGE’s powerful engine daily. Executives in Corporate & New Product Strategy, Launch & Brand Excellence, Value & Access, Primary Market Research and Commercial Analytics are just a few clicks to insights with TrinityEDGE. Launch Accelerator 2.0 is part of LaunchEDGE, an application on TrinityEDGE.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With more than 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit

Media Contact:
Elizabeth Marshall
Trinity Life Sciences

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email